<<

. 13
( 51 .)



>>

membranes. Placenta, 18, 181“8.
Lambert-Messerlian, G. M., Silver, H. M., Petraglia, F. et al. (2000). Second-trimester levels of
maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia
in the third trimester of pregnancy. J. Soc. Gynecol. Invest., 7, 170“4.
Lamharzi, N., Halmos, G., Armatis, P. and Schally, A. V. (1998). Expression of mRNA for
luteinizing hormone-releasing hormone receptors and epidermal growth factor receptors in
human cancer cell lines. Int. J. Oncol., 12, 671“5.
Le Goascogne, C., Eychenne, B., Tonon, M. C. et al. (2000). Neurosteroid progesterone is
up-regulated in the brain of jimpy and shiverer mice. Glia, 29, 14“24.
65 Placental expression of neurohormones and other neuroactive molecules


Leitch, I. M., Boura, A. L., Botti, C. et al. (1998). Vasodilator actions of urocortin and related pep-
tides in the human perfused placenta in vitro. J. Clin. Endocrinol. Metab., 83, 4510“13.
Leung, P. C. and Peng, C. (1996). Gonadotropin-releasing hormone receptor: gene structure,
expression and regulation. Biol. Signals, 5, 63“9.
Lin, L. S., Roberts, V. J. and Yen, S. S. (1995). Expression of human gonadotropin-releasing hor-
mone receptor gene in the placenta and its functional relationship to human chorionic
gonadotropin secretion. J. Clin. Endocrinol. Metab., 80, 580“5.
Linton, E. A., Perkins, A. V., Woods, R. J. et al. (1993). Corticotropin releasing hormone-binding
protein (CRH-BP): plasma levels decrease during the third trimester of normal human preg-
nancy. J. Clin. Endocrinol. Metab., 76, 260“2.
Liotta, A. S. and Krieger, D. T. (1980). In vitro biosynthesis and comparative posttranslational
processing of immunoreactive precursor corticotropin/beta-endorphin by human placental
and pituitary cells. Endocrinology, 106, 1504“11.
Lofgren, M., Holst, J. and Backstrom, T. (1992). Effects in vitro of progesterone and two 5 alpha-
reduced progestins, 5 alpha-pregnane-3,20-dione and 5 alpha-pregnane-3 alpha-ol-20-one,
on contracting human myometrium at term. Acta Obstet. Gynecol. Scand., 71, 28“33.
Luisi, S., Battaglia, C., Florio, P. et al. (1998). Activin A and inhibin B in extra-embryonic
coelomic and amniotic ¬‚uids, and maternal serum in early pregnancy. Placenta, 19, 435“8.
Luisi, S., Petraglia, F., Benedetto, C. et al. (2000). Serum allopregnanolone levels in pregnant
women: changes during pregnancy, at delivery, and in hypertensive patients. J. Clin.
Endocrinol. Metab., 85, 2429“33.
Luisi, S., Florio, P., Reis, F. M. and Petraglia, F. (2001). Expression and secretion of activin A:
possible physiological and clinical implications. Eur. J. Endocrinol., 145, 225“36.
Luisi, S., Florio, P., D™Antona, D. et al. (2003). Maternal serum inhibin A levels are a marker of a
viable trophoblast in incomplete and complete miscarriage. Eur. J. Endocrinol., 148, 233“6.
Lundberg, J. M., Hemsen, A., Fried, G., Theodorsson-Norheim, E. and Lagercrantz, H. (1986).
Co-release of neuropeptide Y (NPY)-like immunoreactivity and catecholamines in newborn
infants. Acta Physiol. Scand., 126, 471“3.
Lurie, S., Fink, A. and Hagay, Z. J. (1997). Parathyroid hormone levels in preterm and term labor.
J. Perinat. Med., 25, 292“4.
MacCannell, K. L., Hamilton, P. L., Lederis, K., Newton, C. A. and Rivier, J. (1984). Corticotropin
releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation.
Gastroenterology, 87, 94“102.
Macgill, K., Moseley, J. M., Martin, T. J. et al. (1997). Vascular effects of PTHrP (1“34) and PTH
(1“34) in the human fetal-placental circulation. Placenta, 18, 587“92.
Mandsager, N. T., Brewer, A. S. and Myatt, L. (1994). Vasodilator effects of parathyroid hormone,
parathyroid hormone-related protein, and calcitonin gene-related peptide in the human
fetal“placental circulation. J. Soc. Gynecol. Invest., 1, 19“24.
Manyonda, I. T., Slater, D. M., Fenske, C. et al. (1998). A role for noradrenaline in pre-eclampsia:
towards a unifying hypothesis for the pathophysiology. Br. J. Obstet. Gynaecol., 105, 641“8.
Margioris, A. N., Grino, M., Protos, P., Gold, P. W. and Chrousos, G. P. (1988). Corticotropin-
releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin
peptides. J. Clin. Endocrinol. Metab., 66, 922“6.
66 F. Petraglia et al.


Marinoni, E., Korebrits, C., Di Iorio, R., Cosmi, E. V. and Challis, J. R. (1998). Effect of
betamethasone in vivo on placental corticotropinreleasing hormone in human pregnancy.
Am. J. Obstet. Gynecol., 178, 770“8.
Mauri, A., Serri, F., Caminiti, F. et al. (1990). Correlation between amniotic levels of alpha-MSH,
ACTH and beta-endorphin in late gestation and labour in normal and complicated pregnan-
cies. Acta Endocrinol. (Copenhagen), 123, 637“42.
McLean, M., Bisit, A., Davies, J. J. et al. (1995). A placental clock controlling the length of human
pregnancy. Nat. Med., 1, 460“3.
Michel, M. C. and Rascher W. (1995). Neuropeptide Y: a possible role in hypertension?
J. Hypertens., 13, 385“95.
Mitchell, B. F. and Schmid, B. (2001). Oxytocin and its receptor in the process of parturition.
J. Soc. Gynecol. Invest., 8, 122“33.
Miyake, A., Sakumoto, T., Aono, T. et al. (1982). Changes in luteinizing hormone-releasing hor-
mone in human placenta throughout pregnancy. Obstet. Gynecol., 60, 444“9.
Moftaquir-Handaj, A., Barbe, F., Barbarino-Monnier, P., Aunis, D. and Boutroy, M. J. (1995).
Circulating chromogranin A and catecholamines in human fetuses at uneventful birth.
Pediatr. Res., 37, 101“5.
Mohan, A., Asselin, J., Sargent, I. L., Groome, N. P. and Muttukrishna, S. (2001). Effect of
cytokines and growth factors on the secretion of inhibin A, activin A and follistatin by term
placental villous trophoblasts in culture. Eur. J. Endocrinol., 145, 505“11.
Moncada, S. and Vane, J. R. (1979). Arachidonic acid metabolites and the interactions between
platelets and blood-vessel walls. New Engl. J. Med., 300, 1142“7.
Muttukrishna, S., Fowler, P. A., George, L., Groome, N. P. and Knight, P. G. (1996). Changes in
peripheral serum levels of total activin A during the human menstrual cycle and pregnancy.
Clin. Endocrinol. Metab., 81, 3328“34.
Muttukrishna, S., Child, T. J., Groome, N. P. and Ledger, W. L. (1997). Source of circulating lev-
els of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum.
Reprod., 12, 1089“93.
Muttukrishna, S., North, R. A., Morris, J. et al. (2000). Serum inhibin A and activin A are elevated
prior to the onset of pre-eclampsia. Hum. Reprod., 15, 1640“5.
Naghashpour, M. and Dahl, G. (2000). Sensitivity of myometrium to CGRP varies during
mouse estrous cycle and in response to progesterone. Am. J. Physiol. Cell. Physiol., 278,
C561“9.
Newnham, J. P., Tomlin, S., Ratter, S. J., Bourne, G. L. and Rees, L. H. (1983). Endogenous opioid
peptides in pregnancy. Br. J. Obstet. Gynaecol., 90, 535“8.
Nguyen, T. T., Tseng, Y. T., McGonnigal, B. et al. (1999). Placental biogenic amine transporters:
in vivo function, regulation and pathobiological signi¬cance. Placenta, 20, 3“11.
Nickols, G. A., Nickols, M. A. and Helwig, J. J. (1990). Binding of parathyroid hormone and
parathyroid hormone-related protein to vascular smooth muscle of rabbit renal microvessels.
Endocrinology, 126, 721“7.
Odagiri, E., Sherrell, B. J., Mount, C. D., Nicholson, W. E. and Orth, D. N. (1979). Human pla-
cental immunoreactive corticotropin, lipotropin, and beta-endorphin: evidence for a com-
mon precursor. Proc. Natl. Acad. Sci. USA, 76, 2027“31.
67 Placental expression of neurohormones and other neuroactive molecules


Padbury, J. F. and Martinez, A. M. (1988). Sympathoadrenal system activity at birth: integration
of postnatal adaptation. Semin. Perinatol., 12, 163“72.
Panerai, A. E., Martini, A., Di Giulio, A. M. et al. (1983). Plasma beta-endorphin, beta-
lipotropin, and met-enkephalin concentrations during pregnancy in normal and drug-
addicted women and their newborn. J. Clin. Endocrinol. Metab., 57, 537“43.
Papantoniou, N. E., Papapetrou, P. D., Antsaklis, A. J. et al. (1996). Circulating levels of
immunoreactive parathyroid hormone-related protein and intact parathyroid hormone in
human fetuses and newborns. Eur. J. Endocrinol., 134, 437“42.
Parida, S. K., Schneider, D. B., Stoss, T. D., Pauly, T. H. and McGillis, J. P. (1998). Elevated circu-
lating calcitonin gene-related peptide in umbilical cord and infant blood associated with
maternal and neonatal sepsis and shock. Pediatr. Res., 43, 276“82.
Pasetto, N., Zicari, A., Piccione, E. et al. (1992). In¬‚uence of labor and oxytocin on in vitro
leukotriene release by human fetal membranes and uterine decidua at term gestation. Am. J.
Obstet. Gynecol., 166, 1500“6.
Pedrazzini, T., Pralong, F. and Grouzmann, E. (2003). Neuropeptide Y: the universal soldier. Cell
Mol. Life Sci., 60, 350“77.
Perkins, A. V., Linton, E. A., Eben, F. et al. (1995) Corticotrophin-releasing hormone and
corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human preg-
nancies. Br. J. Obstet. Gynaecol., 102, 118“22.
Petraglia, F. (1991). Placental neurohormones: secretion and physiological implications. Mol.
Cell. Endocrinol., 78, C109“12.
Petraglia, F. (1997). Inhibin, activin and follistatin in the human placenta “ a new family of reg-
ulatory proteins. Placenta, 18, 3“8.
Petraglia, F., Lim, A. T. and Vale, W. (1987a). Adenosine 3 ,5 -monophosphate, prostaglandins,
and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone
from cultured human placental cells. J. Clin. Endocrinol. Metab., 65, 1020“5.
Petraglia, F., Sawchenko, P., Lim, A. T., Rivier, J. and Vale, W. (1987b). Localization, secretion, and
action of inhibin in human placenta. Science, 237, 187“9.
Petraglia, F., Sawchenko, P. E., Rivier, J. and Vale, W. (1987c). Evidence for local stimulation
of ACTH secretion by corticotropin-releasing factor in human placenta. Nature, 328,
717“9.
Petraglia, F., Calzà, L., Giardino, L. et al. (1989a). Identi¬cation of immunoreactive neuropeptide-
gamma in human placenta: localization, secretion, and binding sites. Endocrinology, 124,
2016“22.
Petraglia, F., Coukos, G., Battaglia, C. et al. (1989b). Plasma and amniotic ¬‚uid immunoreactive
neuropeptide-Y level changes during pregnancy, labor, and at parturition. J. Clin. Endocrinol.
Metab., 69, 324“8.
Petraglia, F., Sutton, S. and Vale, W. (1989c). Neurotransmitters and peptides modulate the
release of immunoreactive corticotropin-releasing factor from cultured human placental cells.
Am. J. Obstet. Gynecol., 160, 247“51.
Petraglia, F., Vaughan, J. and Vale, W. (1989d). Inhibin and activin modulate the release of
gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from
cultured human placental cells. Proc. Natl. Acad. Sci. USA, 86, 5114“17.
68 F. Petraglia et al.


Petraglia, F., Calza, L., Garuti, G. C. et al. (1990a). Presence and synthesis of inhibin subunits in
human decidua. J. Clin. Endocrinol. Metab., 71, 487“92.
Petraglia, F., Calza, L., Garuti, G. C. et al. (1990b). New aspects of placental endocrinology.
J. Endocrinol. Invest., 13, 353“71.
Petraglia, F., Giardino, L., Coukos, G. et al. (1990c). Corticotropin-releasing factor and parturi-
tion: plasma and amniotic ¬‚uid levels and placental binding sites. Obstet. Gynecol., 75, 784“90.
Petraglia, F., Vaughan, J. and Vale, W. (1990d). Steroid hormones modulate the release of
immunoreactive gonadotropin-releasing hormone from cultured human placental cells.
J. Clin. Endocrinol. Metab., 70, 1173“8.
Petraglia, F., Garuti, G. C., Calza, L. et al. (1991). Inhibin subunits in human placenta: localiza-
tion and messenger ribonucleic acid levels during pregnancy. Am. J. Obstet. Gynecol., 165,
750“8.
Petraglia, F., Tabanelli, S., Galassi, M. C. et al. (1992a). Human decidua and in vitro decidualized
endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor
(CRF) and CRF messenger ribonucleic acid. J. Clin. Endocrinol. Metab., 74, 1427“31.
Petraglia, F., Woodruff, T. K., Botticelli, G. et al. (1992b). Gonadotropin-releasing hormone,
inhibin, and activin in human placenta: evidence for a common cellular localization. J. Clin.
Endocrinol. Metab., 74, 1184“8.
Petraglia, F., Anceschi, M. M., Calza, L. et al. (1993a). Inhibin and activin in human fetal mem-
branes: evidence for a local effect on prostaglandin release. J. Clin. Endocrinol. Metab., 77, 542“8.
Petraglia, F., Calzà, L., Giardino, L. et al. (1993b). Maternal decidua and fetal membranes contain
immunoreactive neuropeptide Y. J. Endocrinol. Invest., 16, 201“5.
Petraglia, F., Potter, E., Cameron, V. A. et al. (1993c). Corticotropin-releasing factor-binding pro-
tein is produced by human placenta and intrauterine tissues. J. Clin. Endocrinol. Metab., 77,
919“24.
Petraglia, F., Gallinelli, A., De Vita, D. et al. (1994a). Activin at parturition: changes of maternal
serum levels and evidence for binding sites in placenta and fetal membranes. Obstet. Gynecol.,
84, 278“82.
Petraglia, F., Gallinelli, A., Grande, A. et al. (1994b). Local production and action of follistatin in
human placenta. J. Clin. Endocrinol. Metab., 78, 205“10.
Petraglia, F., Genazzani, A. D., Aguzzoli, L. et al. (1994c). Pulsatile ¬‚uctuations of plasma-
gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy preg-
nant women. Acta Obstet. Gynecol. Scand., 73, 284“9.
Petraglia, F., Aguzzoli, L., Gallinelli, A. et al. (1995a). Hypertension in pregnancy: changes in
activin A maternal serum concentration. Placenta, 16, 447“54.
Petraglia, F., Benedetto, C., Florio, P. et al. (1995b). Effect of corticotropin-releasing factor-
binding protein on prostaglandin release from cultured maternal decidua and on contractile
activity of human myometrium in vitro. J. Clin. Endocrinol. Metab., 80, 3073“6.
Petraglia, F., De Vita, D., Gallinelli, A., et al. (1995c). Abnormal concentration of maternal serum
activin-A in gestational diseases. J. Clin. Endocrinol. Metab., 80, 558“61.
Petraglia, F., Florio, P., Benedetto, C. et al. (1996a). High levels of corticotropin-releasing factor
(CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant
women with pregnancy-induced hypertension. J. Clin. Endocrinol. Metab., 81, 852“6.
69 Placental expression of neurohormones and other neuroactive molecules


Petraglia, F., Florio, P., Gallo, R. et al. (1996b). Corticotropin-releasing factor-binding protein:
origins and possible functions. Horm. Res., 45, 187“91.
Petraglia, F., Florio, P., Gallo, R. et al. (1996c). Human placenta and fetal membranes express
human urocortin mRNA and peptide. J. Clin. Endocrinol. Metab., 81, 3807“10.
Petraglia, F., Florio, P., Nappi, C. and Genazzani, A. R. (1996d). Peptide signaling in human placenta
and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr. Rev., 17, 156“86.
Petraglia, F., Florio, P., Simoncini, T. et al. (1997a). Cord plasma corticotropin-releasing factor-
binding protein (CRF-BP) in term and preterm labour. Placenta, 18, 115“19.
Petraglia, F., Luisi, S., Benedetto, C. et al. (1997b). Changes of dimeric inhibin B levels in mater-
nal serum throughout healthy gestation and in women with gestational diseases. J. Clin.
Endocrinol. Metab., 82, 2991“5.
Petraglia, F., Santuz, M., Florio, P. et al. (1998). Paracrine regulation of human placenta: control
of hormonogenesis. J. Reprod. Immunol., 39, 221“33.
Petraglia, F., Florio, P., Benedetto, C. et al. (1999a). Urocortin stimulates placental adrenocorti-
cotropin and prostaglandin release and myometrial contractility in vitro. J. Clin. Endocrinol.
Metab., 84, 1420“3.
Petraglia, F., Gomez, R., Luisi, S. et al. (1999b). Increased midtrimester amniotic ¬‚uid activin A:
a risk factor for subsequent fetal death. Am. J. Obstet. Gynecol., 180, 194“7.
Plotsky, P. M., Cunningham Jr., E. T. and Widmaier, E. P. (1989). Catecholaminergic modulation
of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev., 10, 437“58.
Plotsky, P. M., Thrivikraman, K. V. and Meaney, M. J. (1993). Central and feedback regulation of
hypothalamic corticotropin-releasing factor secretion. Ciba Found. Symp., 172, 59“75.
Porthe, G., Valette, A. and Cros, J. (1981). Kappa opiate binding sites in human placenta.
Biochem. Biophys. Res. Commun., 101, 1“6.
Porthe, G., Valette, A., Moisand, A., Tafani, M. and Cros, J. (1982). Localization of human pla-
cental opiate binding sites on the syncytial brush border membrane. Life Sci., 31, 2647“54.
Poston, L., McCarthy, A. L. and Ritter, J. M. (1995). Control of vascular resistance in the mater-
nal and feto-placental arterial beds. Pharmacol. Ther., 65, 215“39.
Potter, E., Behan, D. P., Linton, E. A. et al. (1992). The central distribution of a corticotropin-
releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with
CRF. Proc. Natl. Acad. Sci. USA, 89, 4192“6.
Poyner, D. R., Sexton, P. M., Marshall, I. et al. (2002). International Union of Pharmacology.
XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calci-
tonin receptors. Pharmacol. Rev., 54, 233“46.
Rabinovici, J., Goldsmith, P. C., Librach, C. L. and Jaffe, R. B. (1992). Localization and regulation
of the activin-A dimer in human placental cells. J. Clin. Endocrinol. Metab., 75, 571“6.
Ramirez, M. M., Fraher, L. J., Goltzman D. et al. (1995). Immunoreactive parathyroid hormone-
related protein: its association with preterm labor. Eur. J. Obstet. Gynecol. Reprod. Biol., 63,
21“6.
Reis, F. M. and Petraglia, F. (2001). The placenta as a neuroendocrine organ. Front. Horm. Res.
27, 216“28.
Reis, F. M., Fadalti, M., Florio, P. and Petraglia, F. (1999). Putative role of placental corticotropin-
releasing factor in the mechanisms of human parturition. J. Soc. Gynecol. Invest., 6, 109“19.
70 F. Petraglia et al.


Reis, F. M., Florio, P., Cobellis, L. et al. (2001). Human placenta as a source of neuroendocrine
factors. Biol. Neonate., 79, 150“6.
Reis, F. M., D™Antona, D. and Petraglia, F. (2002). Predictive value of hormone measurements in
maternal and fetal complications of pregnancy. Endocr. Rev., 23, 230“57.
Riley, S. C. and Challis, J. R. (1991). Corticotropin-releasing hormone production by the pla-
centa and fetal membranes. Placenta, 12, 105“19.
Riley, S. C., Wathen, N. C., Chard, T., Groome, N. P. and Wallace, E. M. (1996). Inhibin in extra-
embryonic coelomic and amniotic ¬‚uids and maternal serum in early pregnancy. Hum.
Reprod., 11, 2772“6.
Roberts, J. M. and Cooper, D. W. (2001). Pathogenesis and genetics of pre-eclampsia. Lancet,
357, 53“6.
Robidoux, J., Simoneau, L., St-Pierre, S. et al. (1998). Human syncytiotrophoblast NPY receptors
are located on BBM and activate PLC-to-PKC axis. Am. J. Physiol., 274, E502“9.
Robinson, B. G., Emanuel, R. L., Frim, D. M. and Majzoub, J. A. (1988). Glucocorticoid stimu-
lates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad.
Sci. USA, 85, 5244“8.
Rodda, C. P., Kubota, M., Heath, J. A. et al. (1988). Evidence for a novel parathyroid hormone-
related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a
similar protein implicated in humoral hypercalcaemia of malignancy. J. Endocrinol., 117,
261“71.
Rothenberg, S. J., Chicz-DeMet, A., Schnaas, L. et al. (1996). Umbilical cord beta-endorphin and
early childhood motor development. Early Hum. Dev., 46, 83“95.
Russell, J. A., Leng, G. and Douglas, A. J. (2003). The magnocellular oxytocin system, the fount
of maternity: adaptations in pregnancy. Front. Neuroendocrinol., 24, 27“61.
Saijonmaa, X., Laatikainen, T. and Walhstrom, T. (1988). Corticotropin releasing factor in
human placenta: localization, concentration and release in vitro. Placenta, 9, 373“85.
Samuelson, U. E., Dalsgaard, C. J., Lundberg, J. M. and Hokfelt, T. (1985). Calcitonin gene-
related peptide inhibits spontaneous contractions in human uterus and fallopian tube.

<<

. 13
( 51 .)



>>